Madam
Apologies I should have been clearer.
My reference to end of 2017 assumes that US$250m will need to be raised from more than one partner, so assuming MNK sign on and inject e.g. US$125m non-dilutive in Aug17, then the other US$125m could come in the remainder of 2017.
So by the end of 2017, we could have US$250m from two partners (or more).
Of course there could be a deal from Japan/China, a priority review voucher for aGVHD that could spruce up the cash position between now and then.
Then ofcourse there is a chance that non of the above occurs, but if they do - then we are looking at a substantial re-rating, and a well deserved one at that.
Madam Apologies I should have been clearer. My reference to end...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.49 |
Change
0.140(10.4%) |
Mkt cap ! $1.701B | |||
| Open | High | Low | Value | Volume |
| $1.37 | $1.54 | $1.37 | $23.10M | 15.82M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 24758 | $1.49 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.49 | 73626 | 3 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |